ADAP - Adaptimmune GAAP EPS of $0.00 beats by $0.14 revenue of $47.6M May, 12 2023 08:39 AM Adaptimmune Therapeutics plc 2023-05-12 08:39:11 ET Adaptimmune press release ( NASDAQ: ADAP ): Q1 GAAP EPS of $0.00 beats by $0.14 . Revenue of $47.6M (+1222.2% Y/Y). For further details see: Adaptimmune GAAP EPS of $0.00 beats by $0.14, revenue of $47.6M